Lexicon Pharmaceuticals, Inc.
LXRXNASDAQHealthcare● Active
$1.93
+$0.02(+1.05%)
Market Cap$857298280
P/E Ratio—
52W High$2.53
52W Low$0.64
Lexicon Pharmaceuticals, Inc.（LXRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LXRX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $49.80M | $31.08M | $1.20M | $0.14M | $0.30M |
| Cost of Revenue | $0.27M | $0.62M | $58.97M | $52.52M | $55.05M |
| Gross Profit | $49.53M | $30.46M | ($57.77M) | ($52.38M) | ($54.75M) |
| Gross Margin %(computed) | 99.45% | 98.02% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $61.12M | $84.48M | $58.89M | $52.82M | $55.05M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $98.44M | $227.58M | $113.98M | $48.38M | $32.34M |
| Operating Income | ($48.91M) | ($197.12M) | ($171.75M) | ($100.76M) | ($87.09M) |
| Operating Margin %(computed) | -98.21% | -634.20% | — | — | — |
| Interest Income | $6.91M | $12.29M | $7.73M | $1.60M | $0.13M |
| Interest Expense | $8.34M | $15.58M | $13.10M | $2.78M | $0.80M |
| Income Before Tax | ($50.34M) | ($200.40M) | ($177.12M) | ($101.94M) | ($87.76M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($50.34M) | ($200.40M) | ($177.12M) | ($101.94M) | ($87.76M) |
| Net Margin %(computed) | -101.08% | -644.78% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.14 | $-0.63 | $-0.80 | $-0.62 | $-0.61 |
| Wtd Avg Shares | 363.05M | 320.03M | 221.13M | 165.73M | 145.65M |
| EBITDA | ($48.29M) | ($184.29M) | ($169.76M) | ($100.03M) | ($86.80M) |
| EBITDA Margin %(computed) | -96.96% | -592.93% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Lexicon Pharmaceuticals, Inc.
关于Lexicon Pharmaceuticals, Inc.（LXRX）损益表
Lexicon Pharmaceuticals, Inc.（LXRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，LXRX实现营收$0.05B，毛利润$0.05B（毛利率99.45%），净利润($0.05B)（净利率-101.08%）。
常见问题
LXRX · 4 问Lexicon Pharmaceuticals, Inc.（LXRX）2025财年营收为$0.05B，同比up60.2%。
LXRX revenueLXRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08